[1]
Eandi, M. 2004. Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva. Farmeconomia. Health economics and therapeutic pathways. 5, 1 (Mar. 2004), 47–61. DOI:https://doi.org/10.7175/fe.v5i1.786.